Lexaria Bioscience Corp. funding
Lexaria Bioscience Corp., a biotechnology company based in Kelowna, British Columbia, Canada, filed a Form D with the SEC on September 21, 2026 and reported $113K raised. It filed 2 new offerings in this period, totaling $3.6M.
Amount raised$113K
Offering size$113K
Filed with the SECSeptember 21, 2026
First saleSeptember 9, 2026
IndustryBiotechnology
SecuritiesOptions or warrants
LocationKelowna, British Columbia, Canada
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far3
Minimum investment—
Revenue range$5,000,001 - $25,000,000
View the original Form D on SEC EDGAR ↗ · All rounds filed Sep 21
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| September 21, 2026 | $113K | $113K | Options or warrants |
| December 19, 2025 | $3.5M | $3.5M | Options or warrants |
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology